About Tom Mather
Form D filings for MCAL Therapeutics in 2024 list Tom Mather as director.
Tom Mather first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Tom Mather in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tom Mather works with at each company, as listed on that company's latest Form D.
MCAL Therapeutics Inc. · Form D, Mar 27, 2024
TG
Tom Gadek
Chief Executive Officer and director
CN
Charles O'Neill
Director
CM
Chris Murphy
Director
DA
Dan Albert
Director